Vaccines were designed for the Bundibugyo virus that has killed more than 5,300 in the DR Congo.
The World Health Organization (WHO) has approved clinical trials for two new Ebola vaccines, as doctors fight to control the largest outbreak in the history of the Democratic Republic of the Congo (DRC).
On Monday, WHO expert groups recommended adding two vaccine trials designed to fight the Bundibugyo strain, which has killed more than 5,300 people, most in the DRC, since May.
Recommended Stories
list of 3 items list 1 of 3 Attackers kill nurse, injure health worker responding to DRC Ebola case
list 2 of 3 Ebola cases in DR Congo surpass 10,000 in fastest-growing outbreak
list 3 of 3 Incredible celebrations as last patient leaves a DRC Ebola centre
end of list
Public health agencies have struggled to contain the Bundibugyo virus, which has a fatality rate of 50 percent due to the lack of a vaccine or treatments designed specifically for the strain.
WHO chief Tedros Adhanom Ghebreyesus said a trial that…